Sex differences in the efficacy, safety, and tolerability of omalizumab after 1 year in Maltese patients with asthma
- Resource Type
- Short Communication
- Source
- In
Annals of Allergy, Asthma & Immunology April 2017 118(4):513-514 - Subject
- Language
- ISSN
- 1081-1206